English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Corteva signs agreement with Gaïago to develop and distribute biofungicide solutions globallyqrcode

Sep. 9, 2021

Favorites Print
Forward
Sep. 9, 2021

Corteva Agriscience
United States  United States
Follow

Gaïago
France  France
Follow

Corteva, Inc. (NYSE: CTVA) and Gaïago, a biotechnology company, on Wednesday announced a multi-year agreement to validate, develop and commercialize biofungicides for farmers worldwide.


Through the agreement, Corteva Agriscience receives an exclusive, global testing license and associated optional commercial rights for a novel biofungicide technology that can help protect grapevines, potatoes, vegetables, and stone and pome fruits against pathogens such as downy mildew, late blight, powdery mildew and botrytis.


“This agreement furthers our commitment to offering farmers biologicals for crop protection, including tested biofungicide solutions that meet Corteva Agriscience’s high standards in Research & Development,” said Rajan Gajaria, Executive Vice President, Business Platforms, Corteva Agriscience. “Our agreement with Gaïago is another step in demonstrating our efforts in building our biological portfolio by collaborating with the leading experts in their fields.”


“Achieving sustainability in agricultural production as well as a resilient food system requires strong collaborations at all levels,” said Jean-Pierre Princen, President of Gaïago. “This agreement with Corteva will speed up the global introduction of one of our natural biocontrol technologies. This novel biofungicide should be key, both to implement integrated pest management strategies and to meet consumers' expectations, whilst helping to preserve high crop yields and increasing farmers’ income. This global collaboration with Corteva, together with the launch of our joint research programs with scientific institutions in Europe, will boost Gaïago’s large-scale Agrosystems regeneration plans, hence restoring soil and plant functions.”


Corteva’s model for developing its best-in-class Biologicals portfolio combines external innovation, R&D collaboration, licensing, and distribution. This agreement demonstrates how Corteva is targeting collaborations that bring a broad range of external technologies, including well-established companies in the Biologicals space to expand access of a complete set of sustainable solutions in line with the Corteva Agriscience 2030 Sustainability Goals.


Terms of the agreement were not disclosed.



image.png  image.png


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox